Target intelligence / Profile preview

SUCLG2 pseudogene 2 (SUCLG2P2)

Target
SUCLG2P2
Molecular classification
Other (pseudogene)
01

Overview

SUCLG2 pseudogene 2 is a non-functional genomic element related to the SUCLG2 gene, which encodes the beta subunit of succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial[1][2][3]. While the functional SUCLG2 gene participates in the tricarboxylic acid (TCA) cycle, the pseudogene version (SUCLG2P2) does not encode a functional protein and is not involved in cellular metabolism or disease. As a pseudogene, SUCLG2P2 is not considered a target for drug development or therapy. Note: If you meant the functional SUCLG2 gene (not the pseudogene), it encodes a mitochondrial enzyme involved in the TCA cycle, relevant to mitochondrial metabolism and certain rare mitochondrial disorders[1][2][3][5]. However, "SUCLG2P2" specifically refers to the pseudogene, which is genetically inert and not a molecular drug target.

Other names
No established aliases for this pseudogene in major databases; common confusion with functional SUCLG2 or SUCLG2P
02

Mechanism of action

None

03

Biological functions

None (no known biological function because it is a pseudogene)
04

Disease associations

None known; not implicated in disease as an active gene or target

Beyond the preview

Go deeper on SUCLG2 pseudogene 2 (SUCLG2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUCLG2 pseudogene 2 (SUCLG2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call